Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

A new doctoral thesis recently published by Giorgi Beridze at Karolinska Institutet sheds light on the relationship between multimorbidity and kidney health in older adults. The research explores how ...

That vitamin bottle on your kitchen counter promising improved energy, stronger immunity, or enhanced performance might hide an uncomfortable truth – many popular supplements can damage your kidneys ...

Finerenone shows promise in slowing chronic kidney disease progression in non-diabetic patients, according to recent global ...

Scientists have made a remarkable breakthrough in kidney research. In a paper published in the journal Communications Biology, a team of researchers at Kyoto University led by Ramin Sadeghian present ...

A pilot randomized controlled trial in patients with stage 3 chronic kidney disease found that adding roughly one liter of ...

Trutakna, priced at $425,000 per year, is the first drug approved in the U.S. that targets both BAFF and APRIL proteins ...

People living with both obesity and type 2 diabetes face a sharply elevated risk of heart failure, atherosclerotic ...

New research shows people with type 2 diabetes and chronic kidney disease who took semaglutide (commonly sold as Ozempic) once a week had improved kidney outcomes, even if they had heart disease or a ...

Discover the nutrients they all share.

Kidney disease quietly builds in the background, and by the time you actually feel something, the damage may already be ...

A sudden loss of kidney function causes acute kidney injury. However, kidney failure occurs in end stage chronic kidney disease (CKD). While both conditions cause the kidneys to stop working properly, ...